Company OverviewLeadership TeamOur Clients

 

Our Clients

Understanding a consumer's self-management ability is essential to the effective tailoring of support and more effective use of organizational resources. The Patient Activation Measure™ (PAM™) survey provides an essential starting point to these efforts and anchors Insignia's portfolio of tailored programs.

Nearly 40 organizations, including health plans, pharmaceutical firms, hospitals and clinics, Medicaid organizations and disease management firms are using the PAM tool and Insignia's suite of health activation products today. Although these organizations span the healthcare sector, they have a common goal - to use resources more efficiently while providing more effective support.

Disease Management

More than 130 million Americans are managing a disease, most with multiple chronic conditions, resulting in an economic impact approaching $1.5 trillion. Up to 70 percent of this expense is avoidable by modified patient behavior. The PAM instrument provides disease management firms with powerful insight into the self-management competencies of the consumers they serve, allowing coaching interactions and other programs to become better tailored to the needs of a particular consumer. The use of the PAM tool also reduces the reliance on claims data and lengthy health risk assessments (HRAs) that often yield unreliable data to identify coaching opportunities. Disease Management clients include LifeMasters, Davita Village Health, Kaiser Medical, Washington State Medicaid, New York State Medicaid, CareOregon and American Health Holdings.

Drug Therapy Compliance

Pharmaceutical firms and pharmacy benefit managers have a significant stake in patient activation, particularly in the ability to improve medication compliance. Non-compliance is estimated to affect 50 to 70 percent of all prescriptions, cost $100 billion per year and account for 10 percent of all hospitalizations. The PAM tool identifies consumers at-risk for non-compliance and enables the tailoring of care to improve adherence and other self-management behaviors critical to the efficacy of drug therapies. Pharmaceutical clients include AdherenceRx, AstraZeneca and Wyeth-Europe.

Wellness Programs

Employers are increasingly looking to wellness programs to prevent disease, improve employee health, and help control healthcare spending. According to Forrester Research, 74 percent of employers surveyed offer or plan to offer preventive health programs, while 41 percent offer or plan to offer on-site wellness programs. With insights from the PAM survey, lifestyle improvement programs can be better tailored to achieve higher employee participation, program follow-through, and overall effectiveness of the curriculum. Clients using the PAM assessment in wellness efforts include RedBrick Health, Health Future, Mayo Health Plan, and Johns Hopkins Healthcare.

Care Delivery

Interest in thePAM survey has been strong among physicians and care delivery organizations. Clinical settings are staffed lean, patient demand is high, and the typical patient-provider encounter lasts less than ten minutes. Use of thePAM survey– administered in about 3 minutes in advance of a visit or as the consumer waits for an appointment - allows clinicians to tailor interactions with low activation consumers and to direct resources to this high-use, poor self-management group. Outside of the clinical encounter, clinicians and coaches can provide support, including care transition efforts, to those consumers at greatest risk for poor self-care. Clients include Providence Health System, Peace Health, Baylor Medical System, Kaiser Permanente and Fairview Medical System.

Predictive Modeling

Most predictive techniques rely upon historical claims data, biometrics, or consumer-reported health risk assessment (HRA) data. Each has drawbacks not seen with use of the PAM assessment. Claim data is retrospective, often difficult to obtain in an accurate and timely manner, and of little use where a disease has not yet presented. HRA data is affected by socially desirable responses, the need to provide incentive for completion, excessive length, and web-only administrative limitations. Most importantly, HRA data measures behaviors, as opposed to any underlying construct explaining what drives the behaviors.

The PAM assessment offers a powerful tool to augment predictive modeling efforts, as over 130 behaviors and utilization metrics have been mapped to activation levels.

 

Company Overview
Leadership Team
Our Clients


 

The Patient Activation Measure™ (PAM™), developed by Dr. Judy Hibbard and colleagues at the University of Oregon, assesses the knowledge, skills and confidence for managing one’s own health and healthcare.
Learn more about PAM >


 

Learn more about Insignia Health in our Media Center.

Press Releases
Key Facts
Speaking Engagements